A Study to Evaluate the Safety and Immunogenicity of a Single Dose of H1ssF-3928 mRNA-LNP in Healthy Adults
Clinical trial NCT05755620 · COMPLETED
Trial details
- NCT number
- NCT05755620
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-05
- Primary completion
- 2025-10-03
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.